Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

INKTINKT
6 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in MINK THERAPEUTICS INC

Yes. Geode Capital Management holds 15,573 shares of INKT (Mink Therapeutics), worth $182,077, as of its Q2 2026 13F filing. It reduced the position by 1,772 shares (-10.2%) from Q1 2026. Geode Capital Management has held INKT since Q1 2025, across 6 quarterly 13F filings.

Current Value

$182,077

Current Shares

15,573

Total Value Change

+$84,821

Total Shares Change

+4,319

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
15,573
-10.2%
$182,0770.0%$11.69
0
2026-Q1
Increased
17,345
+21.7%
$182,6660.0%$10.53
19
2025-Q4
Increased
14,247
+11.3%
$158,8780.0%$11.15
17
2025-Q3
Increased
12,806
+11.4%
$179,3160.0%$14.00
17
2025-Q2
Increased
11,492
+2.1%
$85,9760.0%$7.39
15
2025-Q1
New
11,254
-
$97,2560.0%$8.64
33

Other major holders of INKT: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, DnB Asset Management AS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used